Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories
(NY:
BIO
)
322.33
-4.00 (-1.23%)
Streaming Delayed Price
Updated: 11:59 AM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bio-Rad Laboratories
< Previous
1
2
3
4
5
6
Next >
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
February 16, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Earnings Scheduled For February 16, 2023
February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...
Via
Benzinga
Earnings Outlook For Bio-Rad Laboratories
February 15, 2023
Via
Benzinga
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
February 07, 2023
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
February 06, 2023
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo.
Via
Investor's Business Daily
Thoughts For Thursday: All Eyes On The CPI
January 12, 2023
All eyes are on the release of the December Consumer Price Index data later today. 2023 has started as a relatively up year for equities and a continued downward trajectory seems necessary to keep the...
Via
Talk Markets
Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
January 06, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
January 04, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio Rad Has Almost 40% Upside On Revenue Acceleration And Margin Improvement, Analyst Says
December 07, 2022
Via
Benzinga
Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference
October 31, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Third-Quarter 2022 Financial Results
October 27, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022
October 17, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
October 28, 2022
During Friday, 125 stocks hit new 52-week lows.
Via
Benzinga
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely
October 11, 2022
One analyst doubts any deal could come to fruition. If it did, it would make sense.
Via
Investor's Business Daily
Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11
October 11, 2022
Reuters US-China Chip War: KLA Relaxes Chip Supply To China
Via
Benzinga
Bio-Rad Laboratories, Qiagen Mull Merger Of Equals
October 11, 2022
Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all.
Via
Benzinga
Bio-Rad Acquires Curiosity Diagnostics
August 03, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Upgrades
Via
Benzinga
Bio-Rad Laboratories: Q2 Earnings Insights
July 28, 2022
Bio-Rad Laboratories (NYSE:BIO) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Bio-Rad Reports Second-Quarter 2022 Financial Results
July 28, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Tesla, Danaher And Some Other Big Gainers From Yesterday
July 22, 2022
U.S. stocks closed higher on Thursday, with the Nasdaq Composite jumping around 1.4%. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
July 22, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...
Via
Benzinga
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
July 21, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending...
Via
Benzinga
Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022
July 18, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Jim Cramer Says This Stock Is 'Too Risky'
July 01, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Cadre Holdings Inc (NYSE: CDRE) as it "makes things, does stuff, sells at a profit, gives you money back."
Via
Benzinga
Bio-Rad Publishes Corporate Sustainability Report
June 27, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
7 Profitable Places to Hide Your Money During a Bear Market
May 13, 2022
With an imminent bear market on the horizon, investors are searching for alternative investment paths for diversification.
Via
InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
May 02, 2022
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Recap: Bio-Rad Laboratories Q1 Earnings
April 28, 2022
Bio-Rad Laboratories (NYSE:BIO) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Bio-Rad Reports First-Quarter 2022 Financial Results
April 28, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.